Document is current
Any future updates will be listed below
-
Authors
Georgopoulou, Dimitra
Callari, Maurizio
Rueda, Oscar M. https://orcid.org/0000-0003-0008-4884
Shea, Abigail
Martin, Alistair
Giovannetti, Agnese https://orcid.org/0000-0001-5207-7243
Qosaj, Fatime
Dariush, Ali
Chin, Suet-Feung https://orcid.org/0000-0001-5697-1082
Carnevalli, Larissa S. https://orcid.org/0000-0001-7432-0195
Provenzano, Elena https://orcid.org/0000-0003-3345-3965
Greenwood, Wendy
Lerda, Giulia
Esmaeilishirazifard, Elham
O’Reilly, Martin
Serra, Violeta https://orcid.org/0000-0001-6620-1065
Bressan, Dario https://orcid.org/0000-0003-3592-699X
,
Ali, H. R.
Al Sa’d, M.
Alon, S.
Aparicio, S.
Battistoni, G.
Balasubramanian, S.
Becker, R.
Bodenmiller, B.
Boyden, E. S.
Bressan, D.
Bruna, A.
Burger, Marcel
Caldas, C.
Callari, M.
Cannell, I. G.
Casbolt, H.
Chornay, N.
Cui, Y.
Dariush, A.
Dinh, K.
Emenari, A.
Eyal-Lubling, Y.
Fan, J.
Fatemi, A.
Fisher, E.
González-Solares, E. A.
González-Fernández, C.
Goodwin, D.
Greenwood, W.
Grimaldi, F.
Hannon, G. J.
Harris, O.
Harris, S.
Jauset, C.
Joyce, J. A.
Karagiannis, E. D.
Kovačević, T.
Kuett, L.
Kunes, R.
Küpcü, Yoldaş A.
Lai, D.
Laks, E.
Lee, H.
Lee, M.
Lerda, G.
Li, Y.
McPherson, A.
Millar, N.
Mulvey, C. M.
Nugent, F.
O’Flanagan, C. H.
Paez-Ribes, M.
Pearsall, I.
Qosaj, F.
Roth, A. J.
Rueda, O. M.
Ruiz, T.
Sawicka, K.
Sepúlveda, L. A.
Shah, S. P.
Shea, A.
Sinha, A.
Smith, A.
Tavaré, S.
Tietscher, S.
Vázquez-García, I.
Vogl, S. L.
Walton, N. A.
Wassie, A. T.
Watson, S. S.
Weselak, J.
Wild, S. A.
Williams, E.
Windhager, J.
Whitmarsh, T.
Xia, C.
Zheng, P.
Zhuang, X.
Mills, Gordon B. https://orcid.org/0000-0002-0144-9614
Ali, H. Raza https://orcid.org/0000-0001-7587-0906
Cosulich, Sabina S.
Hannon, Gregory J.
Bruna, Alejandra
Caldas, Carlos https://orcid.org/0000-0003-3547-1489
-
Funding
Funding for this research was provided by:
Cancer Research UK
EC | Horizon 2020 Framework Programme (ERC-2015-AdG-694620, 660060)
AstraZeneca
- License Information
-
More Information
Article History
Received: 28 August 2020
Accepted: 26 February 2021
First Online: 31 March 2021
Competing interests
: C.C. is a member of AstraZeneca’s iMED External Science Panel, of Illumina’s Scientific Advisory Board, and is a recipient of research grants (administered by the University of Cambridge) from AstraZeneca, Genentech, Roche, and Servier. L.S.C. and S.S.C. are employees and shareholders of AstraZeneca. V.S. received research support from AstraZeneca, Novartis, Genentech and Tesaro. The remaining authors declare no competing interests.
